سعر سيلسيبت 250 مجم 100 كبسولة 2024

Cellcept 250 mg 100 caps.: Mycophenolate mofetil (F. Hoffmann-La Roche).

• Antimetabolite immunosuppressant for prophylaxis of organ rejection in adult and pediatric recipients (≥3 months) of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants (US CELLCEPT).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Contraindicated with history of hypersensitivity (including anaphylaxis) to mycophenolate mofetil, mycophenolic acid or any component; CELLCEPT IV also contraindicated with Polysorbate 80 allergy (US CELLCEPT).International label, same product · DailyMed (U.S. National Library of Medicine)

• Boxed warning: embryofetal toxicity (first-trimester pregnancy loss and congenital malformations); lymphomas and other malignancies especially skin; serious infections including opportunistic infections that may be fatal (US CELLCEPT).International label, same product · DailyMed (U.S. National Library of Medicine)

• Antacids containing magnesium or aluminum hydroxideDecrease MPA systemic exposure; separate administration by at least 2 hours (US CELLCEPT).DailyMed (U.S. National Library of Medicine)
• Proton pump inhibitorsMay decrease MPA exposure; monitor efficacy (US CELLCEPT).DailyMed (U.S. National Library of Medicine)
• Cholestyramine / bile acid sequestrantsInterfere with enterohepatic recirculation and reduce MPA AUC (US CELLCEPT).DailyMed (U.S. National Library of Medicine)

• Pregnancy exposure associated with increased first-trimester pregnancy loss and congenital malformations; avoid if safer options available; females of reproductive potential require contraception counseling and pregnancy testing (US CELLCEPT).International label, same product · DailyMed (U.S. National Library of Medicine)

• Mycophenolate mofetil: Prodrug hydrolyzed to mycophenolic acid (MPA), a selective uncompetitive IMPDH inhibitor that blocks de novo guanosine nucleotide synthesis and lymphocyte proliferation (US CELLCEPT labeling).